These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021. Kurihara K; Wardlaw AJ; Moqbel R; Kay AB J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413 [TBL] [Abstract][Full Text] [Related]
11. Demonstration of reversible priming of human neutrophils using platelet-activating factor. Kitchen E; Rossi AG; Condliffe AM; Haslett C; Chilvers ER Blood; 1996 Dec; 88(11):4330-7. PubMed ID: 8943870 [TBL] [Abstract][Full Text] [Related]
12. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation. Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729 [TBL] [Abstract][Full Text] [Related]
13. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation. Zhou W; Javors MA; Olson MS Arch Biochem Biophys; 1994 Feb; 308(2):439-45. PubMed ID: 8109973 [TBL] [Abstract][Full Text] [Related]
14. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. Földes-Filep E; Braquet P; Filep J Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685 [TBL] [Abstract][Full Text] [Related]
15. Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor. Gómez-Garre D; Guerra M; González E; López-Farré A; Riesco A; Caramelo C; Escanero J; Egido J Eur J Pharmacol; 1992 Dec; 224(2-3):167-72. PubMed ID: 1468506 [TBL] [Abstract][Full Text] [Related]
16. Stimulation and priming of protein kinase C translocation by a Ca2+ transient-independent mechanism. Studies in human neutrophils challenged with platelet-activating factor and other receptor agonists. O'Flaherty JT; Redman JF; Jacobson DP; Rossi AG J Biol Chem; 1990 Dec; 265(35):21619-23. PubMed ID: 2174881 [TBL] [Abstract][Full Text] [Related]
17. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils. Koike H; Imanishi N; Natsume Y; Morooka S Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770 [TBL] [Abstract][Full Text] [Related]
18. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response. Maestre C; Zarco P; Gómez-Guerrero C; González E; Herrero-Beaumont G; Braquet M; Egido J J Lipid Mediat; 1990; 2 Suppl():S151-9. PubMed ID: 1966813 [TBL] [Abstract][Full Text] [Related]
19. PAF-mediated platelet adhesion to endothelial cells induced by FMLP-stimulated leukocytes. Hirafuji M; Shinoda H J Lipid Mediat; 1991 Nov; 4(3):347-51. PubMed ID: 1662550 [TBL] [Abstract][Full Text] [Related]
20. Blood transfusion and the two-insult model of post-injury multiple organ failure. Aiboshi J; Moore EE; Ciesla DJ; Silliman CC Shock; 2001 Apr; 15(4):302-6. PubMed ID: 11303730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]